CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 18 filers reported holding CLEVELAND BIOLABS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,000 | +5.3% | 3,620 | 0.0% | 0.00% | – |
| Q1 2021 | $19,000 | +58.3% | 3,620 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +71.4% | 3,620 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -68.2% | 3,620 | -58.0% | 0.00% | – |
| Q2 2020 | $22,000 | +266.7% | 8,620 | +138.1% | 0.00% | – |
| Q1 2020 | $6,000 | +200.0% | 3,620 | -0.1% | 0.00% | – |
| Q4 2019 | $2,000 | -50.0% | 3,625 | +0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 3,624 | -0.1% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 3,627 | -0.1% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 3,631 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | – | 3,631 | +32909.1% | 0.00% | – |
| Q3 2018 | $0 | – | 11 | +1000.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2015 | $9,000 | – | 2,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 400,080 | $2,188,000 | 0.31% |
| Sequoia Financial Advisors, LLC | 12,588 | $69,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 48,725 | $267,000 | 0.00% |
| Archer Investment Corp | 300 | $1,641,000 | 0.00% |
| Renaissance Technologies | 98,051 | $536,000 | 0.00% |
| VANGUARD GROUP INC | 97,535 | $533,000 | 0.00% |
| FMR LLC | 100 | $1,000 | 0.00% |
| US BANCORP \DE\ | 1,000 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 151 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 51 | $0 | 0.00% |